Camilla Zuckero | Vice President, Investor Relations & Corporate Affairs |
Derek Maetzold | Founder, President & Chief Executive Officer |
Frank Stokes | Chief Financial Officer |
Carl Nixon | Canacord |
Sung Ji Nam | Scotiabank |
Thomas Flaten | Lake Street Capital Markets |
Puneet Souda | SVB |
Mason Carrick | Stevens |
Catherine Schulte | Baird |
Mark Massaro | BTIG |
Good afternoon, and welcome to Castle Biosciences Second Quarter 2023 Conference Call.
As a reminder, today's call is being recorded.
We will begin today's call with opening remarks and introductions, followed by a question-and-answer session.
I would like to turn the call over to Camilla, Vice President, Investor Relations and Corporate Affairs.
Thank you, operator.